Summary & Overview
HCPCS J2371: Phenylephrine Hydrochloride Injection, 20 mcg
HCPCS Level II code J2371 denotes an injection of phenylephrine hydrochloride, 20 micrograms, used for short-acting vasopressor support in acute care settings. Nationally, this code is relevant for hospitals, emergency departments, and procedural suites that administer injectable vasopressors during hemodynamic management. Accurate coding of J2371 affects clinical documentation, billing for medication administration, and aggregate utilization reporting across payers.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, common modifiers and coverage considerations, and how J2371 is treated in relation to other injectable vasopressor codes. The publication provides benchmarks where available, highlights payer coverage patterns, and summarizes the clinical context for use of phenylephrine at this dose.
The analysis is intended for a national audience of billing professionals, hospital administrators, and clinicians involved in procedural and acute care medication administration. It clarifies billing practice elements, payer engagement points, and the role of J2371 in medication administration workflows without offering clinical recommendations.
Billing Code Overview
HCPCS Level II code J2371 represents an injection of phenylephrine hydrochloride, 20 micrograms. This service is an injection medication administration typically used in settings where short-acting vasopressor or hemodynamic support is needed.
-
Service Type: Injection medication administration
-
Typical Site of Service: Hospital inpatient or outpatient procedural areas, emergency department, and other acute care settings where injectable vasopressors are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient ophthalmology clinic or ambulatory surgical center with symptomatic ocular redness, mydriatic need for diagnostic pupillary dilation, or intraoperative hypotension requiring a short-acting vasoconstrictor. The clinician (ophthalmologist or optometrist under protocol, or anesthesiologist in the operating room) prepares a small-dose phenylephrine hydrochloride injection, J2371 (20 micrograms), drawn from a vial or prefilled syringe. The injection may be administered subconjunctivally, intracamerally during anterior segment surgery (for intraoperative pupil dilation), or intravenously in monitored anesthesia care for transient blood pressure support. Typical workflow: patient assessment and informed consent; medication verification and dosing check; topical anesthesia if ocular route; aseptic preparation; administration of J2371; brief monitoring for cardiovascular or ocular adverse effects; documentation of dose, route, time, and patient response in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work or time beyond the usual service is documented (e.g., difficult anesthesia management related to hemodynamic instability after ). |